Donate online
Other ways to give
You can also donate by phone (514 343-6141), in person, by email (anne.lebel@umontreal.ca) or by filling out this donation form and mailing it to IRIC.
One in two Canadians is expected to develop cancer in their lifetime.
One in four Canadians is expected to die from this disease.
The leading cause of death in the country, cancer is a social issue that affects us all. That’s why IRIC needs you to help advance research leading to the discovery of new therapies. By making a donation to IRIC, you are directly contributing to funding research that helps to accelerate the fight against cancer.
Located in the heart of the Université de Montréal, IRIC is a unique research centre in Canada. The Institute groups together, under one roof, a team of Investigators from around the world, a unique university program to train the next generation of scientists and a commercialization hub that accelerates the discovery of novel therapies.
For the past 15 years, your donations have enabled us to reinvent research and to make spectacular advances to shed light on the mechanisms of cancer. Your generosity has resulted in the recruitment of 15 distinguished Investigators, the awarding of over 200 scholarships to the top graduate students, the funding of 21 major innovative projects and the acquisition of cutting-edge equipment, including one device for proteomics and one device for high-throughput screening.
The number of new cancer cases increases each year, mainly because of the aging population. Along with the disastrous consequences for patients and their families, cancer is an enormous burden on society, for its detrimental impact on both the healthcare system and the national economy. In order to reverse that trend, more and more money must be invested to support research. The financing obtained by the major funding organizations is not enough to support research. As a result, developing more effective and better adapted cancer therapies requires a collective effort.
Between now and 2021, IRIC will need your support to raise $10,900,000 ($8,600,000 for the creation of Research Chairs, the recruitment of Investigators and the maintaining of core facilities, $1,300,000 for scholarships and training the next generation of scientists, and $1,000,000 to fund innovative projects). Without you, and without acquiring new knowledge, training the next generation of scientists or maintaining the Institute’s infrastructures, IRIC cannot accelerate the discovery of new therapies.
Investigators use a wide variety of approaches and experimental models and they pool their expertise to create a greater understanding of the mechanisms of cancer. They also strive to develop new diagnostic tools and to discover new therapeutic solutions benefiting patients.
Several research projects funded by our donors are currently in the clinical trial phase in hospitals. One of them, the discovery of the UM171 molecule by Investigator Anne Marinier, Dr. Guy Sauvageau and their teams, has already enabled blood cancer patients to have access to a safe stem cell transplant. The work carried out by Dr. Claude Perreault in immuno-oncology also paves the way for the development of a therapeutic vaccine against leukemia and other types of cancer. Many other novel projects need your support.
To learn more about IRIC’s projects and funding needs, please contact Anne Lebel, Senior Development Advisor, at 514 343-6141 or by email: anne.lebel@umontreal.ca.
The pandemic caused by COVID-19 has created upheaval in our lives and has impacted our activities as well as those of the entire country.
Our Institute is not immune to the situation. We too are deeply affected by the forced stoppage of part of our activities. Many of our laboratories are on hold and the future of our young investigators, along with the completion of several promising projects, are therefore greatly jeopardized.
IRIC wants to create an incubator to foster the excellence of the next generation of scientists. By enriching its offering of scholarships and by properly supporting the training of its young Investigators, the Institute aims to improve their chances for success. And your donations can make that happen.
We must innovate right from the fundamental research step. That said, the types of projects with great potential for new drug discovery are often high-risk and therefore rarely secure funding from traditional public funding organizations. Yet these projects have the capacity to revolutionize the cancer research landscape.
Donate online
Other ways to give
You can also donate by phone (514 343-6141), in person, by email (anne.lebel@umontreal.ca) or by filling out this donation form and mailing it to IRIC.
Your donations contribute to building a cancer-free future. Along with actively funding current research projects, your donations also make it possible for IRIC to initiate promising strategic projects, recruit distinguished Investigators, award scholarships to the top research students and acquire cutting-edge equipment.
Would you like to get involved, become an ambassador for cancer research and organize an event to benefit IRIC?
We are very grateful for your support and the generosity of your initiatives. Please contact us for more information.
Since 2014, IRIC has been organizing the Audacious benefit event, which annually contributes to funding breakthroughs in the fight against cancer. Exceptionally this year, the Institute is offering you a new virtual formula that is just as promising, free of charge, with a view to democratizing science.
Audacious therefore made way for Les Rendez-vous Audace, a series of 3 fascinating and resolutely daring conferences revolving around an inspiring theme: Le temps d’une découverte.
February 4 is World Cancer Day. Every year, it’s a day that is celebrated all over the world to highlight the incredible advances in cancer research that help save more and more lives and create undeniable hope. In memory of those we love who have left us too soon or in honour of those who are currently fighting the disease, let’s all highlight this Day, the progress that we have made and the progress left to be made.
KO Cancer, an initiative led by the IRIC Young Philanthropists
The IRIC Young Philanthropists have rallied to support research and have gotten involved, for the last two years, in the fight against cancer by organizing an annual benefit event, the KO Cancer boxing gala. The 3rd edition took place on Friday, October 18.
In early 2020, IRIC created its brand new “Fonds vaccin thérapeutique contre le cancer”, a fund initiated by Dr. Robert Patenaude with a personal contribution of $25,000. The objective was to support the scientists involved in the project, namely the team led by Dr. Claude Perreault, in collaboration with the teams led by Sébastien Lemieux and Pierre Thibault, who work tirelessly to change the life of people affected by cancer.
Convinced that IRIC’s model contributes to achieving the mission of the Fondation Marcel et Rolande Gosselin, and excited about the recent advances generated by the Institute’s research teams, the Trustees of the Fondation Marcel et Rolande Gosselin announce a $500,000 donation renewal for IRIC’s chemolibrary.
Because the next generation of scientists means so much to them, IRIC’s Chief Executive Officer, Mr. Michel Bouvier, and his partner, Ms. Muriel Aubry, retired Professor and Director of the Department of Biochemistry and Molecular Medicine at the Université de Montréal, are pleased to announce the creation of two endowed funds to support students.
Exceptionally this year, the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal presented a virtual formula of its traditional Audacious fundraising event: Les Rendez-vous Audace. For the occasion, approximately 615 people from 8 countries attended the three free conferences and close to 20 sponsors supported the event. Thanks to the generosity of our partners and donors, a total of $320,000 was raised to accelerate the discovery of better therapies for the benefit of patients.
Only available in French
La Campagne campus de l’Université de Montréal est le rendez-vous philanthropique annuel des membres du personnel de l’Université. Cette année Anne Marinier, chercheuse principale à l’IRIC a accepté de faire partie des 19 ambassadeurs de la campagne. Découvrez son témoignage.
On the occasion of World Cancer Day, IRIC gave the floor to a few of its precious philanthropists who delivered powerful testimonials.
The entire IRIC community extends its warmest thanks to its loyal partners and donors who greatly contribute to the success of our activities and the fight against cancer.
Here is the testimonial of Cyntia Plouffe.
On the occasion of World Cancer Day, IRIC gave the floor to a few of its precious philanthropists who delivered powerful testimonials.
The entire IRIC community extends its warmest thanks to its loyal partners and donors who greatly contribute to the success of our activities and the fight against cancer.
Here is the testimonial of Yvon Chouinard.
As part of a major planned donations campaign, led by the Réseau des diplômés et des donateurs de l’Université de Montréal, Michel Bouvier, Chief Executive Officer of IRIC and his partner, Muriel Aubry, announced their testamentary donation benefiting IRIC and the Department of Biochemistry and Molecular Medicine of the UdeM, in support of cancer research and the training of the next generation of scientists.
For more than 10 years, hundreds of people have taken part in the Défis du Parc and the IRIC Great Challenges against Cancer, have racked up many kilometres to support cancer research efforts, and raised close to $250,000 to recruit and train the next generation of scientists.
On this National Philanthropy Day, IRIC salutes the exceptional commitment made by its Chief Executive Officer, Prof. Michel Bouvier, and his partner, Prof. Muriel Aubry, by announcing their testamentary donation in support of the Université de Montréal and the Institute for Research in Immunology and Cancer (IRIC).
In 1980, over 100% of patients suffering from leukemias would die within two years. At that time, bone marrow transplants were just beginning on an experimental basis and were only being offered to young leukemia patients who had compatible donors. The cure rate was somewhere around 20%, with most patients dying from relapses, severe rejection reactions, infections or hemorrhaging.
During that same time, while I was a second year medical student, during a routine physical, it was discovered that I was severely anemic…
For the past 15 years, many people, foundations and companies have generously contributed to the success of the Institute and the pursuit of its mission. The entire IRIC community wholeheartedly thanks them for their support.
